Doctor profile · Federal record
Dr. Christopher Scully, M.D.
Specialist (CMS: Rheumatology) · Reno, NV
- NPI 1760437842
- Accepts Medicare
- MIPS 56.3 / 100 · 2023
- 42 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
160 Country Estates Cir, Suite #2
Reno, NV 895114040
(775) 322-9100
fax (775) 851-4448
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- August 5, 2009
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Nevada #5990
- Medicaid
- NE #002016046
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760437842. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
75,916
Distinct HCPCS
10
Medicare allowed
$1,084,855
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 47,600 | 17 | $5 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 8,500 | 15 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,300 | 11 | $42 | |
J0897 |
Injection, denosumab, 1 mg | 5,460 | 50 | $23 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 4,180 | 21 | $37 | |
96372 |
Injection of drug or substance under skin or into muscle | 405 | 71 | $14 | |
J7050 |
Infusion, normal saline solution, 250 cc | 392 | 63 | $1 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 260 | 39 | $65 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 239 | 191 | $126 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 201 | 167 | $90 |
In context: peer comparison
Among 6 peers in Reno Specialist, average services per provider: 1,014. This provider delivers 75× the peer median.Open Payments
Industry payments received
All-time total
$161
Transactions
12
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $61.86 | |
| Organon LLC | 5 | $37.19 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $28.12 | |
| GlaxoSmithKline, LLC. | 1 | $17.29 | |
| Ucb, INC. | 1 | $16.92 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,072
Patients
457
Total drug cost
$1,158,126
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 444 | 102 | $16,703 |
| Prednisone | Generic | 314 | 95 | $3,025 |
| Celecoxib | Generic | 210 | 50 | $14,527 |
| Tramadol Hcl | Generic | 157 | 27 | $1,569 |
| Hydroxychloroquine Sulfate | Generic | 151 | 34 | $5,785 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 107 | 18 | $2,581 |
| Meloxicam | Generic | 104 | 21 | $592 |
| Alendronate Sodium | Generic | 90 | 23 | $662 |
| Leflunomide | Generic | 90 | 30 | $7,736 |
| Enbrel Sureclick (Etanercept) | Brand | 83 | 0 | $648,746 |
Hospital affiliations
Frequently asked questions
What is Dr. Christopher Scully's medical specialty?
Dr. Christopher Scully practices Specialist in Reno, NV.
Where does Dr. Christopher Scully practice?
Dr. Christopher Scully practices at 160 Country Estates Cir, Reno, NV 895114040. Office phone: 7753229100.
What is Dr. Christopher Scully's NPI?
Dr. Christopher Scully's National Provider Identifier (NPI) is 1760437842, issued by NPPES.
Does Dr. Christopher Scully accept Medicare assignment?
Yes. Dr. Christopher Scully accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Scully commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.